S'abonner

Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006 - 20/10/11

Doi : 10.1016/j.jaad.2011.04.038 
Hannah K. Weir, PhD a, , Loraine D. Marrett, PhD c, Vilma Cokkinides, PhD d, Jill Barnholtz-Sloan, PhD e, Pragna Patel, MD, MPH b, Eric Tai, MD a, Ahmedin Jemal, DVM, PhD d, Jun Li, MD, PhD, MPH a, Julian Kim, MD, FACS f, Donatus U. Ekwueme, PhD a
a Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 
b Division of HIV/AIDS Prevention, National Center for HIV, Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 
c Population Studies and Surveillance, Cancer Care Ontario, Toronto, Ontario, Canada 
d American Cancer Society, Atlanta, Georgia 
e Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio 
f Department of Surgery, Division of Surgical Oncology, University Hospitals Case Medical Center, Cleveland, Ohio 

Reprint requests: Hannah K. Weir, PhD, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Hwy, MS-K55, Atlanta, GA 30341.

Abstract

Background

Invasive melanoma of the skin is the third most common cancer diagnosed among adolescents and young adults (aged 15-39 years) in the United States. Understanding the burden of melanoma in this age group is important to identifying areas for etiologic research and in developing effective prevention approaches aimed at reducing melanoma risk.

Methods

Melanoma incidence data reported from 38 National Program of Cancer Registries and/or Surveillance Epidemiology and End Results statewide cancer registries covering nearly 67.2% of the US population were used to estimate age-adjusted incidence rates for persons 15-39 years of age. Incidence rate ratios were calculated to compare rates between demographic groups.

Results

Melanoma incidence was higher among females (age-adjusted incidence rates = 9.74; 95% confidence interval 9.62-9.86) compared with males (age-adjusted incidence rates = 5.77; 95% confidence interval 5.68-5.86), increased with age, and was higher in non-Hispanic white compared with Hispanic white and black, American Indians/Alaskan Natives, and Asian and Pacific Islanders populations. Melanoma incidence rates increased with year of diagnosis in females but not males. The majority of melanomas were diagnosed on the trunk in all racial and ethnic groups among males but only in non-Hispanic whites among females. Most melanomas were diagnosed at localized stage, and among those melanomas with known histology, the majority were superficial spreading.

Limitations

Accuracy of melanoma cases reporting was limited because of some incompleteness (delayed reporting) or nonspecific reporting including large proportion of unspecified histology.

Conclusions

Differences in incidence rates by anatomic site, histology, and stage among adolescents and young adults by race, ethnicity, and sex suggest that both host characteristics and behaviors influence risk. These data suggest areas for etiologic research around gene-environment interactions and the need for targeted cancer control activities specific to adolescents and young adult populations.

Le texte complet de cet article est disponible en PDF.

Key words : adolescents, cancer, incidence, melanoma, National Program of Cancer Registries, surveillance, Surveillance Epidemiology and End Results, young adults

Abbreviations used : AI/AN, API, CI, HW, ICD-O, ICD-O-3, NCI, NHW, NOS, NPCR, IRR, SEER, UV, UVR


Plan


 Publication of this supplement to the JAAD was supported by the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention (CDC).
 Conflicts of interest: None declared.
 The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions, recommendations, or official position of the journal editors or the Centers for Disease Control and Prevention.


© 2011  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 65 - N° 5S1

P. S38.e1-S38.e13 - novembre 2011 Retour au numéro
Article précédent Article précédent
  • Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006
  • Xiao-Cheng Wu, Melody J. Eide, Jessica King, Mona Saraiya, Youjie Huang, Charles Wiggins, Jill S. Barnholtz-Sloan, Nicolle Martin, Vilma Cokkinides, Jacqueline Miller, Pragna Patel, Donatus U. Ekwueme, Julian Kim
| Article suivant Article suivant
  • Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure
  • Thomas B. Richards, Christopher J. Johnson, Zaria Tatalovich, Myles Cockburn, Melody J. Eide, Kevin A. Henry, Sue-Min Lai, Sai S. Cherala, Youjie Huang, Umed A. Ajani

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.